Douglas Hogarth to Forced Expiratory Volume
This is a "connection" page, showing publications Douglas Hogarth has written about Forced Expiratory Volume.
Connection Strength
0.424
-
Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE). Respir Med. 2024 04; 224:107565.
Score: 0.206
-
Safety and feasibility of bronchial thermoplasty in asthma patients with very severe fixed airflow obstruction: a case series. J Asthma. 2013 Mar; 50(2):215-8.
Score: 0.095
-
Echocardiography Findings for Pulmonary Hypertension During Workup for Bronchoscopic Lung Volume Reduction. J Bronchology Interv Pulmonol. 2025 Jan 01; 32(1).
Score: 0.055
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 12 01; 200(11):1354-1362.
Score: 0.039
-
Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol. 2016 05; 137(5):1398-1405.e3.
Score: 0.029